semaglutide discontinuation study denmark 2025 september Efficacy and safety of oral monotherapy vs placebo in a predominantly Chinese population with type 2 diabetes (PIONEER 11): a double-blind, Phase IIIa, randomised trial | Diabetologia Titration and discontinuation of semaglutide

Key takeaways While Ozempic (semaglutide)is considered safe, some people may experience mild side effects

Many people who switch report positive outcomes, including greater weight loss and the convenience of once-weekly injections

It has shown little to no proven benefit in HIV-positive patients, who make up a substantial share of global TBM cases

This phase is about establishing tolerance and letting your digestive system adjust

The efficiency of liraglutide was evaluated in the clinical trial called SCALE (Satiety and Clinical Adiposity: Evidence for liraglutide), where it was determined that a dosage of 3.0 mg induced an 8% weight loss equivalent to 8.4 kg of the initial weight in over 56 weeks

How 20 units compares across GLP-1 medications Semaglutide is not the only GLP-1 receptor agonist available